Pharma funds are staging a comeback. After slipping on the return charts in the last six months, pharma funds are topping the charts once again in the last one month. With more than 10% returns in one month, the funds have toppled international sector funds and energy funds which were the toppers in the near term. Fund managers believe that the second deadly wave of covid-19 in India has surely bought the spotlight back on pharma funds. The
MUMBAI: , Goldman Sachs, China Asset Management, FIL Investment (Fidelity), UBS and Schroder Investment are among the bidders for JSW Hydro Energy’s $750-million overseas green bond sale that drew offers more than four times the target, market sources told ET. The company is said to have lowered the funding...
1.Rolls-Royce: –British engineering company Rolls-Royce(OTC:RYCEY) has put its Norwegian maritime engine unit Bergen back on the block, less than two months after Norway blocked a previous deal for it to be bought by a Russian company. “The sale process has restarted,” a source close to the matter said on...
BioNTech plans to set up a regional centre and a new factory in Singapore for its vaccines, it said on Monday, boosting its presence in Asia as a debate over patents rages and pressure grows on drugmakers to raise output of COVID-19 shots. Governments are looking to build up...